Você esta aqui:Home > Sobre nós > Introduction

Introduction

The International Association for Cannbinoid Medicines (IACM) was founded in March 2000. The aim of the association is to advance knowledge on cannabis, cannabinoids, the endocannabinoid system, and related topics especially with regard to their therapeutic potential. The mission is achieved in particular through the following actions:

The IACM declares that it is the right of doctors to be able to discuss the medicinal use of cannabis with their patients.

Membership

There are regular and associate members. Regular members elect the board of directors consisting of up to ten members and decide on the guidelines of the association. Associate members elect up to two patient representatives The patient representatives may participate with equal rights in the meetings of the Board of Directors. The complete statutory articles of the IACM can be downloaded here as a pdf file.

Publications

Members receive the newsletter of IACM (IACM-News). The IACM Bulletin is published in several languages on the internet. Free subscription with the online-form.

Conferência 2020

A IACM vai realizar a sua 11ª Conferência sobre Canabinóides em Medicina de 7 a 9 de Novembro de 2020 na Cidade do México.

Conferência 2021

A 12ª Conferência da IACM sobre Canabinoides em Medicina será realizada em Basileia, Suíça, de 14 a 16 de Outubro de 2021.

Members only

 Please click here to visit the Members Only Area with a film to honour Prof Raphael Mechoulam, 
Please click here to become a member.

IACM on Twitter

Follow us on twitter @IACM_Bulletin where you can send us inquiries and receive updates on research studies and news articles.